» Articles » PMID: 29968300

Multimodality Imaging Agents with PET As the Fundamental Pillar

Overview
Specialty Chemistry
Date 2018 Jul 4
PMID 29968300
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Positron emission tomography (PET) provides quantitative information in vivo with ultra-high sensitivity but is limited by its relatively low spatial resolution. Therefore, PET has been combined with other imaging modalities, and commercial systems such as PET/computed tomography (CT) and PET/magnetic resonance (MR) have become available. Inspired by the emerging field of nanomedicine, many PET-based multimodality nanoparticle imaging agents have been developed in recent years. This Minireview highlights recent progress in the design of PET-based multimodality imaging nanoprobes with an aim to overview the major advances and key challenges in this field and substantially improve our knowledge of this fertile research area.

Citing Articles

Perfluorocarbon-polyepinephrine core-shell nanoparticles as a near-infrared light activatable theranostic platform for bimodal imaging-guided photothermal/chemodynamic synergistic cancer therapy.

Lee K, Park K, Lee S, Lee C Theranostics. 2025; 15(3):1077-1093.

PMID: 39776810 PMC: 11700858. DOI: 10.7150/thno.102743.


Advancements in nanotechnology for diagnostics: a literature review, part II: advanced techniques in nuclear and optical imaging.

Butt A, Bach H Nanomedicine (Lond). 2024; 20(2):183-206.

PMID: 39670826 PMC: 11730800. DOI: 10.1080/17435889.2024.2439778.


Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis.

Chen S, Zhuang D, Jia Q, Guo B, Hu G Biomater Res. 2024; 28:0042.

PMID: 38952717 PMC: 11214848. DOI: 10.34133/bmr.0042.


NIR-II Fluorescent Probes for Fluorescence-Imaging-Guided Tumor Surgery.

Ullah Z, Roy S, Gu J, Ko Soe S, Jin J, Guo B Biosensors (Basel). 2024; 14(6).

PMID: 38920586 PMC: 11201439. DOI: 10.3390/bios14060282.


A PET probe targeting polyamine transport system for precise tumor diagnosis and therapy.

Zhou M, Yin X, Chen B, Hu S, Zhou W Asian J Pharm Sci. 2024; 19(3):100924.

PMID: 38903130 PMC: 11186966. DOI: 10.1016/j.ajps.2024.100924.


References
1.
Hu H, Huang P, Weiss O, Yan X, Yue X, Zhang M . PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters. Biomaterials. 2014; 35(37):9868-9876. PMC: 4180787. DOI: 10.1016/j.biomaterials.2014.08.038. View

2.
Hu Z, Qu Y, Wang K, Zhang X, Zha J, Song T . In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging. Nat Commun. 2015; 6:7560. PMC: 4491820. DOI: 10.1038/ncomms8560. View

3.
Fan Q, Cheng K, Hu X, Ma X, Zhang R, Yang M . Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc. 2014; 136(43):15185-94. PMC: 4227813. DOI: 10.1021/ja505412p. View

4.
Benezra M, Penate-Medina O, Zanzonico P, Schaer D, Ow H, Burns A . Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest. 2011; 121(7):2768-80. PMC: 3223837. DOI: 10.1172/JCI45600. View

5.
Zhou J, Yu M, Sun Y, Zhang X, Zhu X, Wu Z . Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials. 2010; 32(4):1148-56. DOI: 10.1016/j.biomaterials.2010.09.071. View